View of Bioequivalence evaluation of two desvenlafaxine succinate monohydrate formulations 50-mg extended-release coated tablet administered in fasted and fed conditions in healthy male and female volunteers

Return to Article Details Bioequivalence evaluation of two desvenlafaxine succinate monohydrate formulations 50-mg extended-release coated tablet administered in fasted and fed conditions in healthy male and female volunteers Download Download PDF